 The companys results were affected significantly by Chinas zero COVID policy, with Q3 2022 net revenues declining by 35.1 year on year. This policy was abandoned in December 2022, and I expect annualized sales to slowly reclaim the 800 million level and net income to return to about 40 million per year. 